These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24838846)

  • 1. Metabolomics approaches and applications in prostate cancer research.
    Zhang A; Yan G; Han Y; Wang X
    Appl Biochem Biotechnol; 2014 Sep; 174(1):6-12. PubMed ID: 24838846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
    Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
    Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in noninvasive breast cancer.
    Zhang AH; Sun H; Qiu S; Wang XJ
    Clin Chim Acta; 2013 Sep; 424():3-7. PubMed ID: 23669185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative molecular signatures for the imaging of prostate cancer.
    Yang S Y; Adelstein J; Kassis AI
    Expert Rev Mol Diagn; 2010 Jan; 10(1):65-74. PubMed ID: 20014923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.
    Kumar V; Dwivedi DK; Jagannathan NR
    NMR Biomed; 2014 Jan; 27(1):80-9. PubMed ID: 23828638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New opportunities from the cancer metabolome.
    Aboud OA; Weiss RH
    Clin Chem; 2013 Jan; 59(1):138-46. PubMed ID: 23150057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond PSA: are new prostate cancer biomarkers of potential value to New Zealand doctors?
    Ng L; Karunasinghe N; Benjamin CS; Ferguson LR
    N Z Med J; 2012 Apr; 125(1353):59-86. PubMed ID: 22522272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in metabolomics in oncology.
    O'Connell TM
    Bioanalysis; 2012 Feb; 4(4):431-51. PubMed ID: 22394143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The method for early diagnosis of the gastric cancer based metabolomics research].
    Furina RR; Ryzhkov VL; Mitrakova NN; Koptina AV; Safiullin IK; Lychagin KA; Eroshkin PR
    Eksp Klin Gastroenterol; 2014; (10):14-7. PubMed ID: 25911924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New biomarkers in prostate cancer.
    Crawford ED; Ventii K; Shore ND
    Oncology (Williston Park); 2014 Feb; 28(2):135-42. PubMed ID: 24701701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for prostate cancer detection.
    Reed AB; Parekh DJ
    Expert Rev Anticancer Ther; 2010 Jan; 10(1):103-14. PubMed ID: 20014890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of metabolomics to prostate cancer.
    Trock BJ
    Urol Oncol; 2011; 29(5):572-81. PubMed ID: 21930089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics in cancer biomarker discovery: current trends and future perspectives.
    Armitage EG; Barbas C
    J Pharm Biomed Anal; 2014 Jan; 87():1-11. PubMed ID: 24091079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other biomarkers for detecting prostate cancer.
    Nogueira L; Corradi R; Eastham JA
    BJU Int; 2010 Jan; 105(2):166-9. PubMed ID: 19930175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic signatures of malignant progression in prostate epithelial cells.
    Teahan O; Bevan CL; Waxman J; Keun HC
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
    Ni Y; Xie G; Jia W
    J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.